Real-World Evidence (RWE) Price Charts Market Cap Index

Real-World Evidence (RWE) Price Charts Market Cap Index

Real-World Evidence (RWE) Crypto Coin Rank N/A
Website White Paper

Real-World Evidence (RWE)
Real-World Evidence (RWE)
RWE Coin Values RWE

Real-World Evidence (RWE) valuesUSD Price
0

Real-World Evidence (RWE) BTC Price
0

Real-World Evidence (RWE) 24h Vol
0

Real-World Evidence (RWE) Market Cap
0

Real-World Evidence (RWE) Circulating
0

Full Name
Real-World Evidence (RWE)
Start Date
2018-12-10
Algorithm
ETH Token
Proof Type
N/A
Facebook
N/A
Real-World Evidence (RWE) Block NumberBlock Number
N/A
Real-World Evidence (RWE) Block TimeBlock Time
N/A
Real-World Evidence (RWE) Block RewardBlock Reward
N/A
Total Coins Mined
N/A
Max Supply
N/A
Real-World Evidence (RWE) Net Hashes Net Hashes
N/A
Description

Real-World Evidence (RWE) Coin Description

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low-quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs.

Embleema’s next building block is a Real-World Evidence (RWE) marketplace allowing patients to receive treatments and to connect with research. Sharing continuous, individual-patient level data will allow better monitoring of drugs in real-life and accelerate drug availability to patients.

Technology

Real-World Evidence (RWE) Coin Technology

Sorry, detailed technology about Real-World Evidence (RWE) is not currently available

Features

Real-World Evidence (RWE) Coin Features

Sorry, detailed features about Real-World Evidence (RWE) is not currently available

ICO Status

Real-World Evidence (RWE) ICO Details

ICO Status
Ongoing
Token Supply
500000000
Start Date
2018-10-10
End Date
2019-03-31
Fund Raised (BTC)
N/A
Fund Raised (USD)
N/A
Start Price (USD)
0.1734
Security Audit Company
N/A
ICO Legal Form
Corporation
ICO Jurisdiction
France
Legal Advisers
N/A
White Paper

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low-quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs.

Embleema’s next building block is a Real-World Evidence (RWE) marketplace allowing patients to receive treatments and to connect with research. Sharing continuous, individual-patient level data will allow better monitoring of drugs in real-life and accelerate drug availability to patients.

Embleema ICO began on October 10, 2018. The ICO token supply represents 30% of the total token supply, so there is a total of 150,000,000 RWD tokens available, for 0.1734 each. The ICO funding target is 15,000,000 RWD, the funding cap is 150,000,000 RWD and is expected to end on March 31, 2019 or when the funding cap is reached.

Team:

  • Robert Chu: CEO.  
  • Alexis Normand: Head of Blockchain Consortium.  
  • Nicolas Schmidt: Chief Product Officer. 
  • Prashant Khambekar, Ph.D.: Chief Blockchain Development Executive. 

Token Reserve Split (70%):

  • 48% Compensation of Data Owners storing Health Records;
  • 15% Embleema Founders & Advisors;
  • 7% Marketing & Community Development Fund

Embleema ICO features a bounty campaign.

Disqus
Read the Disclaimer: All content provided here on our website, hyperlinked sites, related applications, forums, blogs, social media accounts and other platforms ("Site") is only for your general information, which is obtained from third party sources. We make no guarantees of any kind regarding our content, including but not limited to accuracy and renewal. There is no part of the content that we provide which is financial advice, legal advice or other forms of advice intended for your particular trust in any purpose. Any use or trust in our content is solely at your own risk and wisdom. You must do your own research, review, analyze and verify our content before relying on it. Trading is a very risky activity that can cause big losses, so consult your financial advisor before making a decision.